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ABSTRACT 
BACKGROUND:   
Today oral cancer is considered the sixth most commonly occurring malignancy in the 
world. Oral cancer is usually preceded by several pre-malignant disorders. Tobacco 
usage is considered to be an important etiological reason for oral cancer occurrence. 
Leukoplakia is a premalignant lesion that has a high malignancy transformation rate. 
The early detection of malignant and pre-malignant diseases are necessary for prompt 
treatment and better prognosis.  
AIMS AND OBJECTIVES: 
The aim of the present study was to evaluate and compare the salivary LDH in 
tobacco users, oral leukoplakia, oral squamous cell carcinoma and healthy controls and  
to find out it’s significance in assessing the malignant risk potential. 
MATERIALS AND METHODS: 
The study samples consisted of 4 groups.  29 subjects in the oral squamous cell 
carcinoma group, 26subjects in the oral leukoplakia group, 24 subjects in the tobacco 
users group and 30 healthy controls. Unstimulated saliva was collected, processed and 
biochemically analysed for the salivary LDH value. The data was analysed using 
ANOVA test to compare the mean value between the groups. 
RESULTS: 
The mean value of LDH was significantly higher in OSCC followed by OL, tobacco 
users and healthy controls. The results were statistically significant(P value< 0.005). 
There was insignificant relationship between salivary LDH when correlated with age 
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and gender. There was a significant difference in the mean value of salivary LDH when 
compared between the various histological grades of OSCC. 
CONCLUSION: 
Salivary LDH can be a simple and effective biomarker for the early and prompt 
detection of oral malignancy and pre-malignancy states.  
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